MRUS

AS OF

Nov 13 closing price

Price

$96.08

Change

+$0.04 (+0.04%)

Capitalization

7.29B

110 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MRUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Merus (MRUS) Earnings Date & Reports

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRUS is expected to report earnings to fall 7.14% to -116 cents per share on March 04

Q4'25

Est.

$-1.17

Q3'25

Beat

by $0.12

Q2'25

Missed

by $1.07

Q1'25

Missed

by $0.29

Q4'24

Beat

by $0.48

The last earnings report on November 12 showed earnings per share of -125 cents, beating the estimate of -137 cents. With 759.37K shares outstanding, the current market capitalization sits at 7.29B.

View a ticker or compare two or three

Compare

MRUS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MRUS showed earnings on November 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading for MRUS

A.I. Advisor

published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Uppsalalaan 17

Phone

+31 302538800

Employees

229

Web

https://www.merus.nl